On Tuesday, D.C. Public Schools clarified its policy, telling News4 health professionals will administer medical marijuana to students in schools.

New research utilizing a data-centric approach showed that marijuana significantly reduced the effects of these mental illnesses.

Studies as to how it can help older people, particularly with dementia (Alzheimer's disease being the most common kind of dementia), have been lacking. However, better and newer data is now reported and the results look very promising.

A St. Louis-based marijuana trade industry group announced Thursday morning that it developed a new training program for Missouri doctors, nurses and other healthcare providers.

While more research is needed, existing studies have raised some interesting points about marijuana’s potential role in the fight against high cholesterol and cardiovascular disease.

California schools may soon allow parents to administer medical marijuana to their children on K-12 campuses.

Pancreatic cancer makes up just 3 percent of all cancers in America. But with a one-year survival rate of just 20 percent (and five-year survival rate of less than 8), it’s predicted to be the second leading cause of cancer-related death by 2020.

The Canadian government is scrambling to respond to a glut of license applications for cannabis research prompted by the drug’s legalization in October 2018. The queue of applicants—there were 251 in line as of late July—and the attendant monthslong waiting times are frustrating scientists interested in the basic biology and therapeutic possibilities of cannabis. The delays are also prompting criticism of Health Canada, the agency charged with issuing the permits.

Cannabis has powerful anxiolytic (anti-anxiety) properties, and when administered as-needed, can provide relief from several anxiety disorders.